|
|
||||||||
Ann Thorac Surg 1998;66:821-828
© 1998 The Society of Thoracic Surgeons
a Section of Cardiothoracic Surgery, James W. Riley Hospital for Children and Indiana University Medical Center, Indianapolis, Indiana, USA
Address reprint requests to Dr Bando, Section of Cardiothoracic Surgery, Indiana University Medical Center, 545 Barnhill Dr, EM 215, Indianapolis, IN 46202-5123
Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 2628, 1998.
Background. Modified ultrafiltration (MUF) after cardiopulmonary bypass (CPB) in children decreases body water, removes inflammatory mediators, improves hemodynamics, and decreases transfusion requirements. The optimal target population for MUF needs to be defined. This prospective, randomized study attempted to identify the best candidates for MUF during operations for congenital heart disease.
Methods. Informed consent was obtained from 100 consecutive patients with complex congenital heart disease undergoing operations with CPB. They were randomized into a control group (n = 50) of conventional ultrafiltration during bypass and an experimental group using dilutional ultrafiltration during bypass and venovenous modified ultrafiltration after bypass (MUF group, n = 50). Postoperative arterial oxygenation, duration of ventilatory support, transfusion requirements, hematocrit, chest tube output, and time to chest tube removal were compared between the groups stratified by age and weight, CPB technique, existence of preoperative pulmonary hypertension, and diagnosis.
Results. There were no MUF-related complications. In patients with preoperative pulmonary hypertension, MUF significantly improved postoperative oxygenation (445 ± 129 mm Hg versus control: 307 ± 113 mm Hg, p = 0.002), shortened ventilatory support (42.9 ± 29.5 hours versus control: 162.4 ± 131.2 hours, p = 0.0005), decreased blood transfusion (red blood cells: 16.2 ± 18.2 mL/kg versus control: 41.4 ± 27.8 mL/kg, p = 0.01; coagulation factors: 5.3. ± 6.9 mL/kg versus control: 32.3 ± 15.5 mL/kg, p = 0.01), and led to earlier chest tube removal. In neonates (
30 days), MUF significantly reduced transfusion of coagulation factors (5.4 ± 5.0 mL/kg versus control: 39.9 ± 25.8 mL/kg, p = 0.007), and duration of ventilatory support (59.3 ± 36.2 hours versus 242.1 ± 143.1 hours, p = 0.0009). In patients with prolonged CPB (>120 minutes), MUF significantly reduced the duration of ventilatory support (44.7 ± 37.0 hours versus 128.7 ± 133.4 hours, p = 0.002). No significant differences were observed between MUF and control patients for any parameter in the presence of ventricular septal defect without pulmonary hypertension, tetralogy of Fallot, or aortic stenosis.
Conclusions. Modified ultrafiltration after CPB is safe and decreases the need for homologous blood transfusion, the duration of ventilatory support, and chest tube placement in selected patients with complex congenital heart disease. The optimal use of MUF includes patients with preoperative pulmonary hypertension, neonates, and patients who require prolonged CPB.
This article has been cited by other articles:
![]() |
K. Sung, P. W. Park, K.-H. Park, T.-G. Jun, Y. T. Lee, J.-H. Yang, W. S. Kim, and J. Hwang Is tricuspid valve replacement a catastrophic operation? Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 825 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yokoyama, S. Takabayashi, T. Komada, K. Onoda, Y. Mitani, H. Iwata, and H. Shimpo Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 730 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Osthaus, H Gorler, J Sievers, N Rahe-Meyer, J Optenhofel, T Breymann, G Theilmeier, and R Suempelmann Bicarbonate-buffered ultrafiltration during pediatric cardiac surgery prevents electrolyte and acid-base balance disturbances Perfusion, January 1, 2009; 24(1): 19 - 25. [Abstract] [PDF] |
||||
![]() |
J. Perez-Vela, E Ruiz-Alonso, F Guillen-Ramirez, M. Garcia-Maellas, E Renes-Carreno, M Cerro-Garcia, J Cortina-Romero, and I Hernandez-Rodriguez ICU outcomes in adult cardiac surgery patients in relation to ultrafiltration type Perfusion, March 1, 2008; 23(2): 79 - 87. [Abstract] [PDF] |
||||
![]() |
A. F. Corno Systemic venous drainage: can we help Newton? Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1044 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Williams, C. Ramamoorthy, L. Chu, G. B. Hammer, K. Kamra, M. G. Boltz, K. Pentcheva, J. P. McCarthy, and V. M. Reddy Modified and conventional ultrafiltration during pediatric cardiac surgery: Clinical outcomes compared J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1291 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M Medlin and J. J Sistino Cerebral oxygen saturation changes during modified ultrafiltration Perfusion, November 1, 2006; 21(6): 325 - 328. [Abstract] [PDF] |
||||
![]() |
S. G Raja, S. Yousufuddin, F. Rasool, A. Nubi, M. Danton, and J. Pollock Impact of modified ultrafiltration on morbidity after pediatric cardiac surgery. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 341 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G Raja and G. D Dreyfus Modulation of Systemic Inflammatory Response after Cardiac Surgery Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 382 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-B. S. Mahmoud, M. S. Burhani, A. A. Hannef, A. A. Jamjoom, I. S. Al-Githmi, and G. M. Baslaim Effect of Modified Ultrafiltration on Pulmonary Function After Cardiopulmonary Bypass Chest, November 1, 2005; 128(5): 3447 - 3453. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Riphagen, M. McDougall, S. M. Tibby, N. Alphonso, D. Anderson, C. Austin, A. Durward, and I. A. Murdoch "Early" Delayed Sternal Closure Following Pediatric Cardiac Surgery Ann. Thorac. Surg., August 1, 2005; 80(2): 678 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rodriguez, M. Ruel, L. Broecker, and G. Cornel High Flow Rates During Modified Ultrafiltration Decrease Cerebral Blood Flow Velocity and Venous Oxygen Saturation in Infants Ann. Thorac. Surg., July 1, 2005; 80(1): 22 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Berdat, E. Eichenberger, J. Ebell, J.-P. Pfammatter, M. Pavlovic, C. Zobrist, E. Gygax, U. Nydegger, and T. Carrel Elimination of proinflammatory cytokines in pediatric cardiac surgery: Analysis of ultrafiltration method and filter type J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1688 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Chew Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass? Perfusion, January 1, 2004; 19(1_suppl): S57 - S60. [Abstract] [PDF] |
||||
![]() |
J. W. Gaynor Use of ultrafiltration during and after cardiopulmonary bypass in children J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S98 - 100. [Full Text] [PDF] |
||||
![]() |
M. A Maluf Modified ultrafiltration in surgical correction of congenital heart disease with cardiopulmonary bypass Perfusion, January 1, 2003; 18(1_suppl): 61 - 68. [Abstract] [PDF] |
||||
![]() |
M. S Chew, V. Brix-Christensen, H. B Ravn, I. Brandslund, E. Ditlevsen, J. Pedersen, K. Hjortholm, O. K Hansen, E. Tunnesen, and V. E Hjortdal Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study Perfusion, September 1, 2002; 17(5): 327 - 333. [Abstract] [PDF] |
||||
![]() |
L. Lindberg, A. K. Olsson, P. Jogi, and C. Jonmarker How common is severe pulmonary hypertension after pediatric cardiac surgery? J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1155 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Stephenson Jr and J. L. Myers Pediatric cardiopulmonary bypass Ann. Thorac. Surg., December 1, 2001; 72(6): 2176 - 2177. [Full Text] [PDF] |
||||
![]() |
G. B. Luciani, T. Menon, B. Vecchi, S. Auriemma, and A. Mazzucco Modified Ultrafiltration Reduces Morbidity After Adult Cardiac Operations: A Prospective, Randomized Clinical Trial Circulation, September 18, 2001; 104 (2009): I-253 - I-259. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF] |
||||
![]() |
J. W. Gaynor Use of ultrafiltration during and after cardiopulmonary bypass in children J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 209 - 211. [Full Text] [PDF] |
||||
![]() |
L. D. Thompson, D. B. McElhinney, P. Findlay, W. Miller-Hance, M. J. Chen, M. Minami, E. Petrossian, A. J. Parry, V. M. Reddy, and F. L. Hanley A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 220 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Glogowski, A. H Stammers, K. S Niimi, K. D Tremain, M. L Muhle, and C. C Trowbridge The effect of priming techniques of ultrafiltrators on blood rheology: an in vitro evaluation Perfusion, May 1, 2001; 16(3): 221 - 228. [Abstract] [PDF] |
||||
![]() |
S. T. Verghese Modified Ultrafiltration in Children Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 98 - 104. [Abstract] [PDF] |
||||
![]() |
M. Onoe, T. Magara, Y. Yamamoto, and T. Nojima Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery Perfusion, January 1, 2001; 16(1): 37 - 42. [Abstract] [PDF] |
||||
![]() |
G. J Myers, R. B Leadon, L. B Mitchell, and D. B Ross Simple modified ultrafiltration Perfusion, September 1, 2000; 15(5): 447 - 452. [Abstract] [PDF] |
||||
![]() |
P. D. Yorgin, A. Belson, and K. V. Lemley Continuous Renal Replacement Therapy in Neonates and Young Infants NeoReviews, September 1, 2000; 1(9): e163 - 172. [Full Text] |
||||
![]() |
H. T. Keenan, R. Thiagarajan, K. E. Stephens, G. Williams, C. Ramamoorthy, and F. M. Lupinetti PULMONARY FUNCTION AFTER MODIFIED VENOVENOUS ULTRAFILTRATION IN INFANTS: A PROSPECTIVE, RANDOMIZED TRIAL J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 501 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pearl, P. B. Manning, J. L. McNamara, M. M. Saucier, and D. W. Thomas Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass Ann. Thorac. Surg., October 1, 1999; 68(4): 1369 - 1375. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |